Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Americans largely believe that losing weight can make a big difference both in daily life and in the country as a whole. In ...

Eli Lilly and Novo Nordisk are likely to introduce its popular injectable drugs semaglutide and tirzepatide in India in 2025.

The medicine's popularity has been driven by endorsements from celebrities and influencers. Read more at straitstimes.com.

Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...

The Malaysian Pharmacists Society (MPS) has reportedly raised concerns over a shortage of Ozempic, a diabetes medication, due ...